Cite
HARVARD Citation
Narahara, H. et al. (n.d.). 413PClinical benefits of later line trabectedin and eribulin treatment for soft tissue sarcoma (STS) after pazopanib treatment from the Nishinomiya Sarcoma Cohort Study (NSCS). Annals of oncology. p. . [Online].